SCHEMBL6776332

SCHEMBL6776332

CCc1cc(O)c2c3c(C(N)=O)cccc3n(Cc3cccc(C(F)(F)F)c3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
MAPK10 P53779 1/20 0.43
F10 P00742 1/20 0.42
PARP1 P09874 1/20 0.42
PPARG P37231 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ATM Q13315 2/20 0.41
MAPK8 P45983 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PTGER3 P43115 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
FABP4 P15090 2/20 0.39
FEN1 P39748 1/20 0.39
ICMT O60725 2/20 0.39
GPR52 Q9Y2T5 1/20 0.39
PLA2G1B P04054 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6781743 0.90 TRPV1 (0.45) MAPTMAPK10F10PARP1PPARG
SCHEMBL6897981 0.89 PPARG (0.45) MAPTMAPK10F10PPARGSMN1; SMN2
SCHEMBL6781985 0.89 MAPT (0.44) MAPTMAPK10F10PARP1PPARG
SCHEMBL6693716 0.89 F10 (0.48) MAPTMAPK10F10PARP1PPARG
SCHEMBL6774816 0.87 LMNA (0.43) MAPTF10MAPK8LMNATP53
SCHEMBL6776586 0.87 MAPT (0.42) MAPTMAPK10F10PARP1PPARG
SCHEMBL6777696 0.87 PLA2G2A (0.47) PARP1PLA2G1B
SCHEMBL6776400 0.86 MAPT (0.45) MAPTMAPK10F10PARP1PPARG
SCHEMBL6774766 0.86 ALDH1A1 (0.43) MAPTF10PARP1SMN1; SMN2MAPK8
SCHEMBL6776827 0.85 PLA2G2A (0.53) MAPTMAPK10F10SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed